Martin Whitman - Third Avenue Management
Holding/activity history for Pharmaceutical Product Dev. Inc. (PPDI)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2011 Q4 | 0 | 0.00 | Sell 100.00% | 1.37 | SEC | ||
| 2011 Q3 | 1,741,349 | 1.37 | Reduce 35.14% | 0.61 | $25.66 | $44,683,000 | SEC |
| 2011 Q2 | 2,684,863 | 1.74 | Reduce 2.21% | 0.04 | $26.84 | $72,062,000 | SEC |
| 2011 Q1 | 2,745,653 | 1.67 | Reduce 1.02% | 0.02 | $27.71 | $76,082,000 | SEC |
| 2010 Q4 | 2,774,019 | 1.66 | Reduce 0.95% | 0.02 | $27.14 | $75,287,000 | SEC |
| 2010 Q3 | 2,800,519 | 1.62 | Reduce 3.60% | 0.07 | $24.79 | $69,425,000 | SEC |
| 2010 Q2 | 2,905,079 | 1.91 | Reduce 10.45% | 0.17 | $25.41 | $73,818,000 | SEC |
| 2010 Q1 | 3,244,186 | 1.62 | Add 1.77% | 0.03 | $23.75 | $77,049,000 | SEC |
| 2009 Q4 | 3,187,836 | 1.62 | Reduce 12.63% | 0.21 | $23.44 | $74,723,000 | SEC |
| 2009 Q3 | 3,648,811 | 1.70 | Add 9.88% | 0.15 | $21.94 | $80,055,000 | SEC |
| 2009 Q2 | 3,320,594 | 2.01 | Add 306.33% | 1.52 | $23.22 | $77,104,000 | SEC |
| 2009 Q1 | 817,226 | 0.58 | Buy | 0.58 | $23.72 | $19,385,000 | SEC |
| 2008 Q4 | 0 | 0.00 | Sell 100.00% | 0.15 | SEC | ||
| 2008 Q2 | 25,565 | 0.15 | Reduce 6.26% | 0.01 | $23,309.92 | $595,918,000 | SEC |
| 2008 Q1 | 27,273 | 0.16 | Reduce 63.28% | 1.09 | $23,866.75 | $650,918,000 | SEC |
| 2007 Q4 | 74,270 | 1.73 | Add 13.91% | 0.21 | $11,306.40 | $839,726,000 | SEC |
| 2007 Q3 | 65,200 | 0.52 | Reduce 7.39% | 0.04 | $28,216.66 | $1,839,726,000 | SEC |
| 2007 Q2 | 70,406 | 0.49 | Add 13.59% | 0.06 | $26,130.24 | $1,839,726,000 | SEC |
| 2007 Q1 | 61,980 | 0.55 | Add 4.42% | 0.02 | $29,682.58 | $1,839,726,000 | SEC |
| 2006 Q4 | 59,357 | 0.44 | Buy | 0.44 | $31,036.37 | $1,842,226,000 | SEC |
| 2006 Q1 | 0 | 0.00 | Sell 100.00% | 0.30 | SEC | ||
| 2005 Q4 | 57,878 | 0.30 | Add 7.72% | 0.02 | $16,141.94 | $934,263,000 | SEC |
| 2005 Q3 | 53,729 | 0.31 | Add 22.72% | 0.06 | $17,388.43 | $934,263,000 | SEC |
| 2005 Q2 | 43,780 | 0.41 | Reduce 3.59% | 0.02 | $21,339.95 | $934,263,000 | SEC |
| 2005 Q1 | 45,410 | 0.44 | Reduce 22.94% | 0.03 | $20,640.01 | $937,263,000 | SEC |
| 2004 Q4 | 58,927 | 0.15 | $1,590,549,980.47 | $93,726,338,699,000 | SEC |